The Digestive System

  • Charles H. Duckett
  • John H. GilliamIII

Abstract

The gastrointestinal tract is a complex system responsible for the movement, the digestion, and the absorption of nutrients and water from ingested food and fluids. Because of the large surface area and the multiple neural and chemical elements involved in its function, pathologic states may assume many forms.

Keywords

Acute Pancreatitis Chronic Pancreatitis Gastric Ulcer Hiatus Hernia Family Physician 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    McWhinney IR: Problem solving and decision making in primary medical practice. Can Fam Physician 18 (11): 109–114, 1972.PubMedGoogle Scholar
  2. 2.
    Brock C: Consultation and referral patterns of family physicians. J Fam Pract 4: 1129–1134, 1977.PubMedGoogle Scholar
  3. 3.
    Bruhn GB: Effects of chronic illness on the family. J Fam Pract 4: 1057–1060. 1977.PubMedGoogle Scholar
  4. 4.
    Dent J, Dodds WJ, Friedman RH, et al.: Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest 65: 256–267, 1980.CrossRefPubMedGoogle Scholar
  5. 5.
    Hauser R, Dodds WJ, Patel GK, Dent J, Hogan WJ, Arndorfer RC: Mechanism of gastroesophageal reflux (GER) in patients with reflux esophagitis. Gastroenterology 76: 1153, 1979.Google Scholar
  6. 6.
    Cohen S, Booth GH, Jr: Gastric acid secretion and lower-esophagealsphincter pressure in response to coffee and caffeine. N Engl J Med 293: 897–899, 1975.CrossRefPubMedGoogle Scholar
  7. 7.
    Cohen S: Pathogenesis of coffee-induced gastrointestinal symptoms. N Engl J Med 303: 122–124, 1980.CrossRefPubMedGoogle Scholar
  8. 8.
    Dennish GW, Castell DO: Inhibitory effect of smoking on the lower esophageal sphincter. N Engl J Med 284: 1136–1137, 1971.CrossRefPubMedGoogle Scholar
  9. 9.
    Stanciu C, Bennett JR: Smoking and gastro-oesophageal reflux. Br Med J 3: 793–795, 1972.CrossRefPubMedGoogle Scholar
  10. 10.
    Welch RW, Luckmann K, Ricks P, Drake ST, Bannayan G, Owensby L: Lower esophageal sphincter pressure in histologic esophagitis. Dig Dis Sci 25: 420–426, 1980.CrossRefPubMedGoogle Scholar
  11. 11.
    Helm JF, Riedel DR, Dodds WJ, Hogan WJ, Patel GW, Arndorfer RC: Determinants of esophageal acid clearance in normal subjects. Gastroenterology 78: 1181, 1980.Google Scholar
  12. 12.
    Cohen S, Harris LD: Does hiatus hernia affect competence of the gastroesophageal sphincter? N Engl J Med 284: 1053–1056, 1971.CrossRefPubMedGoogle Scholar
  13. 13.
    Ott DJ, Gelfand DW, Wu WC: Reflux esophagitis: Radiographic and endoscopic correlation. Radiology 130: 583–588, 1979.PubMedGoogle Scholar
  14. 14.
    Bernstein LM, Fruin RC, Pacini R: Differentiation of esophageal pain from angina pectoris: Role of the esophageal acid perfusion test. Medicine (Baltimore) 41: 143–162, 1962.CrossRefGoogle Scholar
  15. 15.
    Behar J, Biancani P, Sheahan DG: Evaluation of esophageal tests in the diagnosis of reflux esophigitis. Gastroenterology 71: 9–15, 1976.PubMedGoogle Scholar
  16. 16.
    Brand DL, Eastwood IR, Martin D, Carter WB, Pope CE II: Esophageal symptoms, manometry, and history before and after antireflux surgery. A long-term fol-Google Scholar
  17. 17.
    Khan TA, Shragge BW, Crispin JS, Lind JF: Esophageal motility in the elderly. Am J Dig Dis 22: 1049 1054, 1977.Google Scholar
  18. 18.
    Castell DO: The aging esophagus. Dig Dis Sci 23: 667, 1978.CrossRefGoogle Scholar
  19. 19.
    Vantrappen G, Janssens J, Hellemans J, Coremans G: Achalasia, diffuse esophageal spasm, and related motility disorders. Gastroenterology 76: 450–457, 1979.PubMedGoogle Scholar
  20. 20.
    Bennett JR, Hendrix TR: Diffuse esophageal spasm: A disorder with more than one cause. Gastroenterology 59: 273–279, 1970.PubMedGoogle Scholar
  21. 21.
    Rubin P: Cancer of the gastrointestinal tract. JAMA 226: 1544–1546, 1973.CrossRefPubMedGoogle Scholar
  22. 22.
    Wynder EL, Bross IJ: A study of etiological factors in cancer of the esophagus. Cancer 14: 389–413, 1961.CrossRefPubMedGoogle Scholar
  23. 23.
    Heit HA, Johnson LF, Siegel SR, Boyce HW Jr: Palliative dilation for dysphagia in esophageal carcinoma. Ann Intern Merl R9•699–631 1978Google Scholar
  24. 24.
    Wright JT: Slipping-rib syndrome. Lancet 2: 632–633, 1980.CrossRefPubMedGoogle Scholar
  25. 25.
    Cocco AE, Cocco DV: A survey of cimetidine poisoning. N Engl J Med 304: 1281–1284, 1981.CrossRefPubMedGoogle Scholar
  26. 26.
    Jensen KG: Peptic ulcer: Genetic and epidemiologic aspects based on twin studies. Copenhagen, Munksgaard, 1972.Google Scholar
  27. 27.
    Rotter JI, Sones JQ Samloff IM, et al.: Duodenal-ulcer disease associated with elevated serum pepsinogen I: An inherited autosomal dominant disorder. N Engl J Med 300: 63–66, 1979.CrossRefPubMedGoogle Scholar
  28. 28.
    Korman MG, Shaw RG, Hansky J, Schmidt GT, Stern AI: Influence of smoking on healing rate of duodenal ulcer in response to cimetidine or high-dose antacid. Gastroenterology 80: 1451–1453, 1981.PubMedGoogle Scholar
  29. 29.
    Paffenbarger RS Jr, Wing AL, Hyde RT: Chronic disease in former college students: XIII. Early precursors of peptic ulcer. Am J Epidemiol 100: 307–315, 1974.PubMedGoogle Scholar
  30. 30.
    Grossman MI, Guth PH, Isenberg JI, et al.: A new look at peptic ulcer. Ann Intern Med 84: 57–67, 1976.CrossRefPubMedGoogle Scholar
  31. 31.
    McMillan DE, Freeman RB: The milk-alkali syndrome: A study of the acute disorder with comments on the development of the chronic condition. Medicine (Baltimore) 44: 485–501, 1965.CrossRefGoogle Scholar
  32. 32.
    Ippoliti AF, Maxwell V, Isenberg JI: The effect of various forms of milk on gastric-acid secretion: Studies in patients with duodenal ulcer and normal subjects. Ann Intern Med 84: 286–289, 1976.CrossRefPubMedGoogle Scholar
  33. 33.
    Babouris N, Fletcher J, Lennard Jones JE: Part II. Effect of varying the size and frequency of meals. Gut 6: 118–120, 1965.CrossRefPubMedGoogle Scholar
  34. 34.
    Morris T, Rhodes J: Progress report: Antacids and peptic ulcer-a reappraisal. Gut 20: 538–545, 1979.CrossRefPubMedGoogle Scholar
  35. 35.
    Fordtran JS, Morawski SG, Richardson CT: In vivo and in vitro evaluation of liquid antacids. N Engl J Med 288: 923–928, 1973.CrossRefPubMedGoogle Scholar
  36. 36.
    Fordtran JS, Collyns JAH: Antacid pharmacology in duodenal ulcer: Effect of antacids on postcibal gastric acidity and peptic activity. N Engl J Med 274: 921–927, 1966.CrossRefPubMedGoogle Scholar
  37. 37.
    Peterson WL, Sturdevant RAL, Frankl HD: Healing of duodenal ulcer with an antacid regimen. N Engl J Med 297: 341–345, 1977.CrossRefPubMedGoogle Scholar
  38. 38.
    Sturdevant RAL, Isenberg JI, Secrist D, Ansfield J: Antacid and placebo produced similar pain relief in duodenal ulcer patients. Gastroenterology 72: 1–5, 1977.PubMedGoogle Scholar
  39. 39.
    Hetzel DJ, Hansky J, Shearman DJC, et al.: Cimetidine treatment of duodenal ulceration: Short-term clinical trial and maintenance study. Gastroenterology 74: 389–392, 1978.PubMedGoogle Scholar
  40. 40.
    Winship DH: Cimetidine in the treatment of duodenal ulcer: Review and commentary. Gastroenterology 74: 402–406, 1978.PubMedGoogle Scholar
  41. 41.
    Ippoliti AF, Sturdevant RAL, Isenberg JI: Cimetidine versus intensive antacid therapy for duodenal ulcer: A multicenter trail. Gastroenterology 74: 393395, 1978.Google Scholar
  42. 42.
    Fedeli G, Anti M, Rapaccini GL, DeVitis I, Butti A, Civello IM: A controlled study comparing cimetidine treatment to an intensive antacid regimen in the therapy of uncomplicated duodenal ulcer. Dig Dis Sci 24: 758–762, 1979.CrossRefPubMedGoogle Scholar
  43. 43.
    McCarthy DM: Peptic ulcer: Antacids or cimetidine? Hosp Pract (12)14: 52–58, 63–64, 1979.Google Scholar
  44. 44.
    McGuigan JE: A consideration of the adverse effects of cimetidine. Gastroenterology 80: 181–192, 1981.PubMedGoogle Scholar
  45. 45.
    Posnett DN, Stein RS, Graber SE, Krantz SB: Cimetidine-induced neutropenia: A possible dose-related phenomenon. Arch Intern Med 139: 584–586, 1979.CrossRefPubMedGoogle Scholar
  46. 46.
    Freston JW: Cimetidine and granulocytopenia. Ann Intern Med 90: 264–265, 1979.CrossRefPubMedGoogle Scholar
  47. 47.
    Carloss HW, Tavassoli M, McMillan R: Cimetidineinduced granulocytopenia. Ann Intern Med 93: 57–58, 1980.CrossRefPubMedGoogle Scholar
  48. 48.
    McDaniel JL, Stein JJ: Thrombocytopenia with cimetidine therapy. N Engl J Med 300: 864, 1979.PubMedGoogle Scholar
  49. 49.
    Van Thiel DH, Gavaler JS, Smith WI Jr, Paul G: Hypothalamic-pituitary-ganadal dysfunction in men using cimetidine. N Engl J Med 300: 1012–1015, 1979.CrossRefPubMedGoogle Scholar
  50. 50.
    Avella J, Madsen JE, Binder HJ, Askenase PW: Effect of histamine H2-receptor antagonists on delayed hypersensitivity. Lancet 1: 624–626, 1978.CrossRefPubMedGoogle Scholar
  51. 51.
    Delaunois L: Hypersensitivity to cimetidine. N Engl J Med 300: 1216, 1979.PubMedGoogle Scholar
  52. 52.
    McMillen MA, Ambis D, Siegel JH: Cimetidine and mental confusion. N Engl J Med 298: 294–295, 1978.Google Scholar
  53. 53.
    Gugler R, Somogyi A: Reduced cimetidine clearance with age. N Engl J Med 301: 435, 1979.CrossRefPubMedGoogle Scholar
  54. 54.
    Feely J, Wilkinson GR, Wood AJJ: Reduction of liver blood flow and propranolol metabolism by cimetidine. N Engl J Med 304: 692–695, 1981.CrossRefPubMedGoogle Scholar
  55. 55.
    Klotz U, Reimann I: Delayed clearance of diazepam due to cimetidine. N EnglJ Med 302: 1012–1014, 1980.CrossRefGoogle Scholar
  56. 56.
    Weinberger MM, Smith G, Milavetz G: Decreased theophylline clearance due to cimetidine. N Engl J Med 304: 672, 1981.PubMedGoogle Scholar
  57. 57.
    Silver BA, Bell WR: Cimetidine potentiation of the hypoprothrombinemic effect of warfarin. Ann Intern Med 90: 348–349, 1979.CrossRefPubMedGoogle Scholar
  58. 58.
    Serlin MJ, Sibeon RG, Mossman S, Breckenridge AM: Cimetidine: Interaction with oral anticoagulants in man. Lancet 2: 317–319, 1979.CrossRefPubMedGoogle Scholar
  59. 59.
    Fry J: Peptic ulcer: A profile. Br Med J 2: 809–812, 1964.CrossRefPubMedGoogle Scholar
  60. 60.
    Greibe J, Bugge P, Gjorup T, Lauritzen T, Bonnevie O, Wulff HR: Long-term prognosis of duodenal ulcer: Follow-up study and survey of doctors’ estimates. Br Med J 2: 1572–1574, 1977.CrossRefPubMedGoogle Scholar
  61. 61.
    Dronfield MW, Batchelor AJ, Larkworthy W, Langman MJS: Controlled trial of maintenance cimetidine treatment in healed duodenal ulcer: Short-and long-term effects. Gut 20: 526–530, 1979.CrossRefPubMedGoogle Scholar
  62. 62.
    Bardham KD, Saul DM, Edwards JL, et al.: Double-blind comparison of cimetidine and placebo in the maintenance of healing of chronic duodenal ulceration. Gut 20: 158–162, 1979.CrossRefGoogle Scholar
  63. 63.
    Gudmand-Hoyer E, Birger Jensen K, Krag E, et al.: Prophylactic effect of cimetidine in duodenal ulcer disease. Br Med J 1: 1095–1097, 1978.CrossRefPubMedGoogle Scholar
  64. 64.
    Gray GR, Smith IS, Mackenzie I, Gillespie G: Longterm cimetidine in the management of severe duodenal ulcer dyspepsia. Gastroenterology 74: 397–401, 1978.PubMedGoogle Scholar
  65. 65.
    Blackwood WS, Mandgal DP, Northfield TC: Prevention by bedtime cimetidine of duodenal-ulcer relapse. Lancet 1: 626–627, 1978.CrossRefPubMedGoogle Scholar
  66. 66.
    Bodemar G, Walan A: Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet 1: 403–407, 1978.CrossRefPubMedGoogle Scholar
  67. 67.
    Machell RJ, Ciclitira PJ, Farthing MJG, Dick AP, Hunter JO: Maintenance cimetidine in prevention of peptic-ulcer relapse. Lancet 1: 663, 1978.CrossRefPubMedGoogle Scholar
  68. 68.
    Cargill JM, Peden N, Saunders JHB, Wormsley KG: Very long-term treatment of peptic ulcer with cimetidine. Lancet 2: 113–115, 1978.Google Scholar
  69. 69.
    Fisher RS, Cohen S: Pyloric-sphincter dysfunction in patients with gastric ulcer. N Engl J Med 288: 273276, 1973.Google Scholar
  70. 70.
    Conn HO, Blitzer BL: Nonassociation of adrenocorticosteroid therapy and peptic ulcer. N Engl J Med 294: 473–479, 1976.CrossRefPubMedGoogle Scholar
  71. 71.
    Englert E Jr, Freston JW, Graham DY, et al.: Cimetidine, anatacid, and hospitalization in the treatment of benign gastric ulcer: A multi-center double blind study. Gastroenterology 74: 416–425, 1978.PubMedGoogle Scholar
  72. 72.
    Sircus W: Progress report: Carbenoxolone sodium. Gut 13: 816–824, 1972.CrossRefPubMedGoogle Scholar
  73. 73.
    Caruso I, Binachi Porro G: Gastroscopic evaluation of anti-inflammatory agents. Br Med J 1: 75–77, 1980.CrossRefGoogle Scholar
  74. 74.
    Mann NS: Bile-induced erosive gastritis: its prevention by antacid, cholestgramine, and prostaglandin E2. Dig Dis 21: 89–92, 1976.CrossRefGoogle Scholar
  75. 75.
    Kivilaakso E, Silen W: Pathogenesis of experimental gastric-mucosal injury. N Engl J Med 301: 364–369, 1979.CrossRefPubMedGoogle Scholar
  76. 76.
    Lanza FL, Royer GL, Nelson RS: Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 303: 136–138, 1980.CrossRefPubMedGoogle Scholar
  77. 77.
    Hastings PR, Skillman JJ, Bushnell LS, Silen W: Antacid titration in the prevention of acute gastrointestinal bleeding: A controlled, randomized trial in 100 critically ill patients. N Engl J Med 298: 1041–1045, 1978.CrossRefPubMedGoogle Scholar
  78. 78.
    Solem LD, Strate RG, Fischer RP: Antacid therapy and nutritional supplementation in the prevention of Curling’s ulcer. Surg Gynecol Obstet 148: 367–370, 1979.PubMedGoogle Scholar
  79. 79.
    Priebe HJ, Skillman JJ, Bushnell LS, Long PC, Silen W: Antacid versus cimetidine in preventing acute gastrointestinal bleeding: A randomized trial in 75 critically ill patients. N Engl J Med 302: 426–430, 1980.CrossRefPubMedGoogle Scholar
  80. 80.
    Morris DW, Levine GM, Soloway RD, Miller WT, Marin GA: Prospective randomized study of diagnosis and outcome in acute upper-gastrointestinal bleeding: Endoscopy versus conventional radiography. Am J Dig Dis 20: 1103–1109, 1975.CrossRefPubMedGoogle Scholar
  81. 81.
    Keller RT, Logan GM Jr: Comparison of emergent endoscopy and upper gastrointestinal series radiography in acute upper gastrointestinal hemorrhage. Gut 17: 180–184, 1976.CrossRefPubMedGoogle Scholar
  82. 82.
    Peterson WL, Barnett CC, Smith HJ, Allen MH, Corbett DB: Routine early endoscopy in upper-gastrointestinal-tract bleeding. N Engl J Med 304: 925–929, 1981.CrossRefPubMedGoogle Scholar
  83. 83.
    Eastwood GL: Does early endoscopy benefit the patient with active upper gastrointestinal bleeding? Gastroenterology 72: 737–739, 1977.PubMedGoogle Scholar
  84. 84.
    Morrisey JF, Winans CS: The emergency endoscopy controversy. Dig Dis 22: 534–540, 1977.Google Scholar
  85. 85.
    Dronfield MW, Mclllmurray MB, Ferguson R, Atkinson M, Langman MJS: A prospective, randomized study of endoscopy and radiology in acute upper-gastrointestinal-tract bleeding. Lancet 1: 1167–1169, 1977.CrossRefPubMedGoogle Scholar
  86. 86.
    Conn HO: To scope or not to scope. N Engl J Med 304: 967–969, 1981.CrossRefPubMedGoogle Scholar
  87. 87.
    Griffith WJ, Neumann DA, Welsh JD: The visible vessel as an indicator of uncontrolled or recurrent gastrointestinal hemorrhage. N Engl J Med 300: 1411 1413, 1979.Google Scholar
  88. 88.
    Blacklow NR, Cukor G: Viral gastroenteritis. N Engl J Med 304: 397–406, 1981.CrossRefPubMedGoogle Scholar
  89. 89.
    Brandborg LL: Other infectious, inflammatory and miscellaneous diseases. In: Sleisenger MH, Fordtran JS (eds.) Gastrointestinal Disease. Philadelphia, Saunders, 1978, pp. 1076–1093.Google Scholar
  90. 90.
    Grady GE, Keusch GT: Pathogenesis of bacterial diarrhea. N Engl J Med 285: 831–841, 1971.CrossRefPubMedGoogle Scholar
  91. 91.
    Sullivan MA, Cohen S, Snape WJ Jr: Colonic myoelectrical activity in irritable-bowel syndrome. N Engl J Med 298: 878–883, 1978.CrossRefPubMedGoogle Scholar
  92. 92.
    Whitehead WE, Engel BT, Schuster MM: Irritable-bowel syndrome: Physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig Dis Sci 25: 404–413, 1980.CrossRefPubMedGoogle Scholar
  93. 93.
    Clearfield HR: Therapy of spastic colon. Am Fam Physician 15 (5): 176–177, 1977.PubMedGoogle Scholar
  94. 94.
    Gear JSS, Ware A, Fursdon P, et al.: Symptomless diverticular disease and intake of dietary fibre. Lancet 1: 511–514, 1979.CrossRefPubMedGoogle Scholar
  95. 95.
    Kirsner JB: The local and systemic complications of inflammatory bowel disease. JAMA 242: 1177–1183, 1979.CrossRefPubMedGoogle Scholar
  96. 96.
    Farmer RG, Hawk WA, Turnbull RB: Clinical patterns in Crohn’s disease. Gastroenterology 68: 627–635, 1975.PubMedGoogle Scholar
  97. 97.
    Laufer I, Hamilton J: Radiological differentation between ulcerative colitis and granulomatous colitis by double contrast radiology. Am J Gastroenterol 66: 259–269, 1976.PubMedGoogle Scholar
  98. 98.
    Devroede G, Taylor WF: On calculating cancer risk and survival of ulcerative colitis patients with the life table method. Gastroenterology 71: 505–509, 1976.PubMedGoogle Scholar
  99. 99.
    Moore TL, Kupchik HZ, Marcon N: Carcinoembryonic antigen assay in cancer of the colon and other digestive tract disorders. Am J Dig Dis 16: 1, 1971.CrossRefPubMedGoogle Scholar
  100. 100.
    Winawer J: S.., •-g for colorectal cancer: An over- view. Cancer 45: 1093–1098, 1980.CrossRefPubMedGoogle Scholar
  101. 101.
    Erbe RW: Inherited gastrointestinal-polyposis syndromes. N Engl J Med 294: 1101–1104, 1976.CrossRefPubMedGoogle Scholar
  102. 102.
    Morson BC: Genesis of colorectal cancer. In: Sherlock P, Zamcheck N (eds.) Clinics in Gastroenterology. Philadelphia, Saunders, 1976, pp. 505–525.Google Scholar
  103. 103.
    Muto T, Bussey HJR, Morson BC: The evolution of cancer of the colon and rectum. Cancer 36: 2251–2270, 1975.CrossRefPubMedGoogle Scholar
  104. 104.
    Fung CHK, Goldman H: The incidence and significance of villous change in adenomatous polyps. Am J Clin Pathol 53: 21–25, 1970.PubMedGoogle Scholar
  105. 105.
    Tedesco FJ, Waye JD, Avella JR, Villalobos MM: Diagnostic implications of the spatial distribution of colonic mass lesions (polyps and cancers): A prospective colonoscopie study. Gastrointest Endosc 26: 95–97, 1980.CrossRefPubMedGoogle Scholar
  106. 106.
    Burkitt DP: Epidemiology of cancer of the colon and rectum. Cancer 28: 3–13, 1971.CrossRefPubMedGoogle Scholar
  107. 107.
    American Cancer Society: ‘78 Cancer Facts and Figures. New York City, 1977.Google Scholar
  108. 108.
    Winnan G, Berci G, Parrish J, Talbot TM, Overholt BF, McCallum RW: Superiority of the flexible to the rigid sigmoidoscope in routine proctosigmoidoscopy. N Engl J Med 302: 1011–1012, 1980.CrossRefPubMedGoogle Scholar
  109. 109.
    Gelfand DW, Ott DJ: Single-vs. double-contrast gastrointestinal studies: Critical analysis of reported statistics. Am J Radiol 137: 523–528, 1981.Google Scholar
  110. 110.
    Overholt BF: Colonoscopy: A review. Gastroenterology 68: 1308–1320, 1975.PubMedGoogle Scholar
  111. 111.
    Witt TR, Winawer SJ: Cancer in a colonic polyp, or malignant colonic adenomas-is polypectomy sufficient? Gastroenterology 81: 625–630, 1981.Google Scholar
  112. 112.
    Beart RW, Jr, van Heerden JA, Beahrs OH: Evolution in the pathologic staging of carcinoma of the colon. Surg Gynecol Obstet 146: 257–259, 1978.PubMedGoogle Scholar
  113. 113.
    Cathcart PM, Cathcart RS, Rambo WM: Management of lower gastrointestinal bleeding. Am Surg 43: 217219, 1977.Google Scholar
  114. 114.
    Almy TP, Howell DA: Diverticular disease of the colon. N Engl J Med 302: 324–331, 1980.CrossRefPubMedGoogle Scholar
  115. 115.
    Weaver GA, Alpern HD, Davis JS, Ramsey WH, Reichelderfer M: Gastrointestinal angiodysplasia associated with aortic valve disease: Part of a spectrum of angiodysplasia of the gut. Gastroenterology 77: 111, 1979.Google Scholar
  116. 116.
    Motson RW, Way LW: Differential diagnosis of gallbladder disease. Hosp Med 3: 26–46, 1977.Google Scholar
  117. 117.
    Way LW, Sleisenger MH: Cholelithiasis and chronic cholecystitis. In: Sleisenger MH, Fordtran JS (eds.) Gastrointestinal Disease. Philadelphia, Saunders, 1978, pp. 1294–1302.Google Scholar
  118. 118.
    Schoenfield LJ, Lachin JM, The Steering Committee and the National Cooperative Gallstone Study Group: Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: The National Cooperative Gallstone Study. Ann Intern Med 95: 257–282, 1981.CrossRefPubMedGoogle Scholar
  119. 119.
    Webster PD, Spainhour JB: Pathophysiology and management of acute pancreatitis. Hosp Pract 12: 59–66, 1974.Google Scholar
  120. 120.
    Geokas MS: Acute pancreatitis. Ann Intern Med 76: 105–117, 1972.CrossRefPubMedGoogle Scholar
  121. 121.
    Warshaw AL, Fuller AF Jr: Specificity of increased renal clearance of amylase in diagnosis of acute pancreatitis. N Engl J Med 292: 325–328, 1975.CrossRefPubMedGoogle Scholar
  122. 122.
    Levitt MD, Rapoport M, Cooperband SR: The renal clearance of amylase in renal insufficiency, acute pancreatitis, and macroamylasemia. Ann Intern Med 71: 919–925, 1969.CrossRefPubMedGoogle Scholar
  123. 123.
    Levitt MD, Johnson SG: Is the Cam/Ccr ratio of value for the diagnosis of pancreatitis? Gastroenterology 75: 118–119, 1978.PubMedGoogle Scholar
  124. 124.
    Soergel KH: Medical treatment of acute pancreatitis: What is the evidence? Gastroenterology 74: 620–621, 1978.PubMedGoogle Scholar
  125. 125.
    Strum WB, Spiro HM: Chronic pancreatitis. Ann Intern Med 74: 264–277, 1971.CrossRefPubMedGoogle Scholar
  126. 126.
    Melnyk CS: Carcinoma of the pancreas. In: Sleisenger MH, Fordtran JS (eds.) Gastrointestinal Disease. Philadelphia, WB Saunders, 1978, pp. 1457–1467.Google Scholar
  127. 127.
    Krugman S, Friedman H, Lattimer C: Viral hepatitis, type A: Identification by specific complement fixation and immune adherence tests. N Engl J Med 292: 1141–1143, 1975.CrossRefPubMedGoogle Scholar
  128. 128.
    Bradley DW, Maynard JE: Serodiagnosis of viral hepatitis A by radioimmunoassay. Lab Management 9: 2934, 1978.Google Scholar
  129. 129.
    Seeff LB, Hoofnagle JH: Immunoprophylaxis of viral hepatitis. Gastroenterology 77: 161–182, 1979.PubMedGoogle Scholar
  130. 130.
    Rosenberg JL, Jones DP, Lipitz LR, Kirsner JB: Viral hepatitis: An occupational hazard to surgeons. JAMA 223: 395–400, 1973.CrossRefPubMedGoogle Scholar
  131. 131.
    Krugman S, Giles JP: Viral hepatitis: New light on an old disease. JAMA 212: 1019–1029, 1970.CrossRefPubMedGoogle Scholar
  132. 132.
    Seeff LB, Wright EC, Zimmerman HJ, et al.: Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin: Final report of the Veterans Administration Cooperative Study. Ann Intern Med 88: 285–293, 1978.CrossRefPubMedGoogle Scholar
  133. 133.
    Redeker AG, MosleyJW, Gocke DJ, McKee AP, Pollack W: Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis. N Engl J Med 293: 1055–1059, 1975.CrossRefPubMedGoogle Scholar
  134. 134.
    Szmuness W, Stevens CE, Harley EJ, et al.: Hepatitis B vaccine: Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 303: 833–841, 1980.CrossRefPubMedGoogle Scholar
  135. 135.
    Aach RD, Kahn RA: Post-transfusion hepatitis: Current perspectives. Ann Intern Med 92: 539–546, 1980.CrossRefPubMedGoogle Scholar
  136. 136.
    Shirachi R, Shiraishi H, Tateda A, Kikuchi K, Ishida N: Hepatitis “C” antigen in non-A, non-B post-transfusion hepatitis. Lancet 2: 853–856, 1978.CrossRefPubMedGoogle Scholar
  137. 137.
    Yoshizawa H, Itoh Y, Iwakiri S, et al.: Demonstration of two different types of non-A, non-B hepatitis by reinjection and cross-challenge studies in chimpanzees. Gastroenterology 81: 107–113, 1981.PubMedGoogle Scholar
  138. 138.
    Alter HJ, Purcell RH, Holland PV, Feinstone SM, Morrow AG, Moritsuga Y: Clinical and serological analysis of transfusion-associated hepatitis. Lancet 2: 838–841, 1975.CrossRefPubMedGoogle Scholar
  139. 139.
    Tabor E, Seeff LB, Gerety RJ: Chronic non-A, non-B hepatitis carrier state: Transmissible agent documented in one patient over a six-year period. N Engl J Med 303: 140–143, 1980.CrossRefPubMedGoogle Scholar
  140. 140.
    Zimmerman HJ: Hepatotoxicity. New York, AppletonCentury-Crofts, 1978.Google Scholar
  141. 141.
    Redeker AG: Treatment of chronic active hepatitis: Good news and bad news. N Engl J Med 304: 420421, 1981.Google Scholar
  142. 142.
    Reynolds TB, Ito S, Iwatsuki S: Measurement of portal pressure and its clinical application. Am J Med 49: 649657, 1970.Google Scholar
  143. 143.
    Soloway RD, Baggenstoss AH, Schoenfield LJ, Summerskill WHJ: Observer error and sampling variability tests in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis 16: 1082–1086, 1971.CrossRefPubMedGoogle Scholar
  144. 144.
    Czaja AJ, Ludwig J, Baggenstoss AH, Wolf A: Corticosteroid-treated chronic active hepatitis in remission. Uncertain prognosis of chronic persistent hepatitis. N Engl J Med 304: 5–9, 1981.CrossRefPubMedGoogle Scholar
  145. 145.
    Sternlieb I, Scheinberg IH: Chronic hepatitis as a first manifestation of Wilson’s disease. Ann Intern Med 76: 59–64, 1972.CrossRefPubMedGoogle Scholar
  146. 146.
    Cook GC, Mulligan R, Sherlock S: Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. QJ Med 158: 159–185, 1971.Google Scholar
  147. 147.
    Murray-Lyon IM, Stern RB, Williams R: Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet 1: 735–737, 1973.CrossRefPubMedGoogle Scholar
  148. 148.
    Soloway RD, Summerskill WHJ, Baggenstoss AH, et al.: Clinical, biochemical, and histologic remission of severe chronic active liver disease: A controlled study of treatments and early prognosis. Gastroenterology 63: 820–833, 1972.PubMedGoogle Scholar
  149. 149.
    Summerskill WHJ, Korman MG, Ammon HV, Baggenstoss AH: Prednisone for chronic active liver disease: Dose titration, standard dose, and combination with azathioprine compared. Gut 16: 876–883, 1975.CrossRefPubMedGoogle Scholar
  150. 150.
    Lam KC, Lai CL, Trepo C, Wu PC: Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med 304: 380–386, 1981.CrossRefPubMedGoogle Scholar
  151. 151.
    Koretz RL, Suffin SC, Gitnick GL: Post-transfusion chronic liver disease. Gastroenterology 71: 797–803, 1976.PubMedGoogle Scholar
  152. 152.
    Plotz PH: Asymptomatic chronic hepatitis. Gastroen terology 68: 1629–1630, 1975.Google Scholar
  153. 153.
    U.S. Department of Health, Education and Welfare: Third special report of the U.S. Congress on alcohol and health from the Secretary of Health, Education and Welfare, Washington, D.C., XI: June, 1978.Google Scholar
  154. 154.
    Lieber CS, Rubin E: Alcoholic fatty liver in man on a high protein and low fat diet. Am J Med 44:200–206, 1968.Google Scholar
  155. 155.
    Van Thiel DH, Lipsitz HD, Porter LE: Gastroin testinal and hepatic manifestations of chronic alcoholism. Gastroenterology 81: 594–615, 1981.Google Scholar
  156. 156.
    Borowsky SA, Strome S, Lott E: Continued heavy drinking and survival in alcoholic cirrhotics. Gastroen terology 80: 1405–1409, 1981.Google Scholar
  157. 157.
    Powell WJ, Jr, Klatskin G: Duration of survival in patients with Laennec’s cirrhosis: Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med 44: 406–419, 1968.CrossRefPubMedGoogle Scholar
  158. 158.
    Lischner MW, Alexander JF, Galambos JT: Natural history of alcoholic hepatitis: I. The acute disease. Am J Dig Dis 16: 481–494, 1971.CrossRefPubMedGoogle Scholar
  159. 159.
    Galambos JT: Cirrhosis. Philadelphia, Saunders, 1979.Google Scholar
  160. 160.
    Nasrallah SM, Galambos JT: Aminoacid therapy of alcoholic hepatitis. Lancet 2: 1276–1277, 1980.CrossRefPubMedGoogle Scholar
  161. 161.
    Epstein M: Deranged sodium homeostasis in cirrhosis. Gastroenterology 76: 622–635, 1979.PubMedGoogle Scholar
  162. 162.
    Gregory PB, Broeckelschen PH, Hill MD: Complications of diuresis in the alcholic patient with ascites: A controlled trial. Gastroenterology 73: 534–538, 1977.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • Charles H. Duckett
  • John H. GilliamIII

There are no affiliations available

Personalised recommendations